Alterity Therapeutics (ATHE) Cash from Discontinued Operations (2009 - 2016)

Alterity Therapeutics' Cash from Discontinued Operations history runs 6 years deep, the most recent figure standing at 465813.11 for Q4 2016.

• On a quarterly basis, Cash from Discontinued Operations rose 91.23% year-over-year to 465813.11 in Q4 2016; TTM through Dec 2016 was 6933575121472.9, a 0.0% change from a year earlier, with the FY2024 full-year figure at 12605824.0, changed N/A from the prior year.
• Cash from Discontinued Operations rose to 465813.11 in Q4 2016 per ATHE's latest filing, from 5310262.34 in the prior quarter.
• Across five years, Cash from Discontinued Operations topped out at 465813.11 in Q4 2016 and bottomed at 6933562150191.48 in Q2 2014.
• The 3-year median for Cash from Discontinued Operations is 6252734.16 (2015), against an average of 1733393780368.22.
• Across the five-year window, Cash from Discontinued Operations gained 26.2% in 2015 and soared 91.23% in 2016, its largest moves.
• Year by year, Cash from Discontinued Operations stood at 7195205.97 in 2014, then rose by 26.2% to 5310262.34 in 2015, then jumped by 91.23% to 465813.11 in 2016.
• Per Business Quant, the three latest ATHE Cash from Discontinued Operations figures stand at 465813.11 (Q4 2016), 5310262.34 (Q4 2015), and 7195205.97 (Q4 2014).